Option chain shows key data for Alvotech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Alvotech.

Alvotech (NASDAQ:ALVO) Stock, Option Chain

Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Stuttgart,,Germany,-,05-30-2021:,Person,Holding,Smartphone,With,Logo,Of

News

Health Care

Contracts

Movers

Trading Ideas

General

ALVO

Alvotech and Dr. Reddy&#39;s will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.

Dr Reddy&#39;s And Alvotech Join Hands To Develop Biosimilar For Merck&#39;s Blockbuster Cancer Drug

Teva Pharmaceuticals

Biotech

Large Cap

AXSM

TEVA

Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design.

Why Is Teva Stock Trading Higher On Tuesday?

Milan,,Italy,-,August,10,,2017:,Groupon,Website,Homepage.,It.

Intraday Update

Markets

AXON

CVNA

DAVE

EPAM

GRPN

MELI

PAYC

QBTS

QDEL

RVMD

SEZL

STKL

VTRS

Groupon Posts Upbeat Earnings, Joins Axon Enterprise, Warner Bros. Discovery, MercadoLibre And Other Big Stocks Moving Higher On Thursday

ALVOPETRO ENEGY LTD by Alvopetro Energy Ltd

Alvopetro Energy Ltd

ALVO MINERALS LTD by ALVO MINERALS LTD.

Press Releases

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025

Earnings

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update

Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada

Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe

Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY

Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million

Alvotech and Dr. Reddy's Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami

Alvotech's Private Placement Completed with Delivery of SDRs and Shares to Investors

Ascentage Pharma Group International - American Depository Shares

Ascentage Pharma Group

ACADIA Pharmaceuticals Inc. - Common Stock

ACADIA Pharmaceuticals

Arcellx

Apogee Therapeutics

Apellis Pharmaceuticals, Inc. - Common Stock

Apellis Pharmaceuticals

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharma

Catalyst Pharmaceuticals, Inc. - Common Stock

Catalyst Pharmaceuticals

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals

Cytokinetics, Incorporated - Common Stock

Cytokinetics

ImmunityBio

Immunovant

Krystal Biotech

Kymera Therapeutics

Mirum Pharmaceuticals, Inc. - common stock

Mirum Pharmaceuticals

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

Metsera

Protagonist Therapeutics, Inc. - Common Stock

Protagonist Therapeutics

Ultragenyx Pharmaceutical Inc. - Common Stock

Ultragenyx Pharmaceutical

Avidity Biosciences

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

Scholar Rock Holding Corporation - Common Stock

Scholar Rock Holding

SpringWorks Therapeutics, Inc. - common stock

SpringWorks Therapeutics

Vericel

Veracyte

Viking Therapeutics

Barclays

Citigroup

Deutsche Bank

Morgan Stanley

Comments

Alvotech

Alvotech (ALVO) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell